HALIX to Expand Production of Proteins, Viral Products at New cGMP Facility

HALIX, a Dutch contract development and manufacturing organization (CDMO) focused on clinical and commercial proteins and viral products, has marked the interim completion of a new cGMP facility that will specialize in developing and producing biopharmaceutical drug substances.
Sartorius Lab

Sartorius Launches New Mammalian Cell Bank Manufacturing Services

Sartorius Stedim Biotech (SSB) launched new services for mammalian cell bank manufacture under GMP conditions.
Pharmaceutical Bioreactors

908 Devices Receives Grant to Modernize Bioprocess Analytics

The mission of NIIMBL is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a biopharmaceutical manufacturing workforce.
Bioreactors in lab

Overview of Scale-Down Screening Models for Cell Culture

Scale-down models need to exactly mimic the critical process parameter to be studied and optimized. Considering this, there are probably still some gaps with regards to scale-down solutions in upstream and downstream process development, particularly for continuous applications. The most accurate models use miniature bioreactors because these do a good job of replicating results seen in benchtop instruments.
MilliporeSigma M Lab Collaboration Center

Single-Use Technology Has Biopharma Sizing Up the Recycling Bin

Waste manifests itself in different forms. To take its measure, don’t just look at plastic waste. Add up all the waste caused by washing, sterilization, inflexible workflows, and lost productivity.
Monoclonal Antibodies

Biomanufacturing Expands Its Comfort Zone

Biomanufacturers want more flexibility, productivity, and profit. And they’ll do more to secure these gains if they feel at ease with process intensification and continuous manufacturing.
Repligen’s XCell™ ATF cell retention devices

All Roads Lead to Continuous Processing

End-to-end configurations may seem to be where continuous processing should lead, but the technology also encompasses intermediate goals such as upstream and downstream intensification.
Dendritic cell and T-lymphocytes, illustration

Automated Reproducible Dendritic Cell Production

Market-leading Corning entered into an agreement with Flaskworks to commercialize MicroDEN, an automated fluidic system that allows for differentiation of monocytes into DCs utilizing continuous perfusion of differentiation media.

Recently Featured

Stay Connected

Scroll Up